Graypoint LLC’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$234K Buy
25,194
+5,000
+25% +$46.4K 0.01% 489
2025
Q1
$148K Buy
+20,194
New +$148K 0.01% 499